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Protecting children from environmental
hazards is a daunting task. Environmental toxi-
cants, such as lead, methylmercury, tobacco,
and other pollutants covertly enter children’s
body via placental transfer during fetal growth,
inhalation or ingestion of house dust, soil,
breast milk, and other dietary sources during
early childhood (Landrigan et al. 1998; Perera
et al. 2003). Exposures to these toxicants have
been linked with the new “morbidities” of
childhood—intellectual impairments, behav-
ioral problems, asthma, and preterm birth
(Lanphear et al. 2005b). These and innumer-
able other environmental chemicals can regu-
larly be detected in young children and women
of reproductive age [Centers for Disease
Control and Prevention (CDC) 2005].
Respiratory toxicants are so commonplace that
we accept as inevitable that over 4 million U.S.
children will develop asthma (Akinbami And
Schoendorf 2002)—many through exposure
to airborne pollutants (Gauderman et al. 2004;
Gent et al. 2003; McConnell et al. 2002).
Despite a profound attachment to our own
children and intense rhetoric about the value
of children, society has been unwilling to
invest the resources or develop regulations that
are necessary to protect children from environ-
mental hazards. 
A new framework to protect children from
environmental hazards is an ethical imperative.
Given the increasing evidence linking children’s
exposures to environmental hazards with
adverse health consequences, a framework to
protect children from environment hazards
must include regulations to test new chemicals
and other potential hazards before they are
marketed. It must include a strategy to conduct
research necessary to protect children from per-
sistent hazards that are widely dispersed in their
environment. It must provide a regulatory
mechanism to implement policy that will elim-
inate human exposures to recognized and sus-
pected toxicants. Finally, it must contain
guidelines about the ethical conduct of
research and the role of experimental trials that
test the efﬁcacy and safety of interventions to
prevent or ameliorate children’s exposure to
persistent toxicants. 
Protecting Children from
Toxicants
Regulations to protect children from environ-
mental chemicals are evolving. In the 1960s,
following the epidemic of phocomelia from
thalidomide, regulations were developed to
protect pregnant women from exposure to ter-
atogenic drugs—drugs that induce either
structural or functional abnormalities (Hilts
2003). These regulations require premarket
testing to ensure the safety and efficacy of
pharmacologic agents. 
Since then, it has become increasingly clear
that pregnant women are often inadvertently
exposed to numerous environmental teratogens
(CDC 2005). Fetal and early childhood expo-
sures to environmental toxicants, such as lead,
methylmercury, polychlorinated biphenyls, and
tobacco smoke, have been associated with an
increased risk for premature birth, spontaneous
abortions, delinquency and conduct disorder,
intellectual deﬁcits or attention deﬁcit hyperac-
tivity disorder (Baghurst et al. 1992; Boroja-
Aburto et al. 1999; Dietrich et al 2001; Fried
et al. 1998; Grandjean et al. 1997; Jaakkola
et al. 2001; Jacobson and Jacobson 1996;
Lanphear et al. 2005a; Longnecker et al. 2001;
Needleman et al. 1979; Schantz et al. 2003;
Wakschlag et al. 2002; Weitzman et al. 2002;
Windham et al. 1999; Yolton 2005). Many
scientists and pediatricians are increasingly
troubled about the inadequacy of the regulatory
framework to protect children from environ-
mental toxicants. 
From an ethical perspective, exposure of
pregnant women to environmental teratogens
is no different than exposure to teratogenic
drugs. The vast majority of pesticides and
other environmental chemicals in use have not
been tested for reproductive toxicity or devel-
opmental neurotoxicity (Claudio et al. 1999,
2000). Indeed, 75% of “high production vol-
ume” chemicals, deﬁned as chemicals that are
produced at > 1 million pounds per year, lack
even the most basic toxicity testing (Claudio
et al. 1999, 2000). The ethical imperative to
protect the fetus and children from teratogenic
environmental chemicals is ultimately no dif-
ferent than the imperative to protect them
from teratogenic drugs. To protect children
from environmental toxicants and hazards,
society must require premarket testing of envi-
ronmental chemicals before they are marketed
(Lanphear at al. 2005b). 
Society’s failure to regulate chemicals for
reproductive and neurodevelopmental toxicity
raises profound ethical questions. In the
absence of toxicity testing, we are inadver-
tently employing pregnant women and chil-
dren as uninformed subjects to warn us of
new environmental toxicants. Our regulatory
system relies heavily on epidemiologic studies
to identify environmental hazards, but epi-
demiologic studies are difﬁcult to mount and
often require years to complete (Taubes
1995). Moreover, human studies of environ-
mental toxicants are typically observational in
design and it is inherently difficult to infer
causality from such studies. Paradoxically,
because industry is not obligated to supply the
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Society is increasingly aware of the profound impact that the environment has on children’s health.
Not surprisingly, there is increasing public scrutiny about children’s exposures to environmental
hazards, especially for disadvantaged children. These trends underscore the ethical imperative to
develop a framework to protect children from environmental hazards. Such a framework must
include regulations to test new chemicals and other potential hazards before they are marketed, a
strategy to conduct research necessary to protect children from persistent hazards that are widely
dispersed in their environment, stronger regulatory mechanisms to eliminate human exposures to
recognized or suspected toxicants, and guidelines about the ethical conduct of research and the role
of experimental trials that test the efﬁcacy and safety of interventions to prevent or ameliorate chil-
dren’s exposure to persistent toxicants or hazards that are widely dispersed in their environment.
Key words: assent, children, consent, controls, environmental exposure, ethics, health, prevention,
policy, research. Environ Health Perspect 114:1609–1612 (2006). doi:10.1289/ehp.9001 available
via http://dx.doi.org/ [Online 14 August 2006]data on developmental neurotoxicity, the costs
of human disease, research, and prevention are
socialized whereas the profits are privatized.
Finally, once a chemical is at last deemed
toxic, the large expense necessary to eliminate
an exposure is invariably used as an argument
that cleanup or abatement is unaffordable. 
The Role of Experimental Trials
in Environmental Health
Research
Once a persistent toxicant or hazard is widely
disseminated in the environment, different
types of research are necessary to ensure that
we protect children. For recognized toxicants
or hazards, our ﬁrst impulse is to eliminate it.
This is justiﬁed for many environmental haz-
ards, such as installing window guards to pre-
vent falls, reducing emissions of airborne
pollutants, using safety caps for prescription
drugs and banning nonpersistent pesticides.
But the solution is not always so evident;
indeed, even if the solution appeared obvious
to experts, it may be shown years later that it
was neither safe nor efficacious. The use of
impermeable mattress covers that were stan-
dard therapy for asthma control for over two
decades was subsequently shown to be ineffec-
tive (Woodcock et al. 2003). Efforts to protect
children from asbestos and lead by abatement
inadvertently increased exposure for many
children (Lanphear 1998; Mossman et al.
1990). We can, despite our best intentions,
cause irreparable harm to children.
Unlike studies of pharmaceutical agents,
we continue to rely heavily on observational
studies and expert opinion for controlling envi-
ronmental threats to children. Experimental
trials (or randomized controlled trials) have
been underused in environmental health
research. Compared with observational studies,
experimental trials can provide more defini-
tive evidence about the causal relationship of
an environmental hazard with a specific dis-
ease or disability. They can also be used to
test the safety and efficacy of environmental
interventions to reduce children’s exposures to
environmental hazards. 
Controlled trials of environmental interven-
tions, such as lead abatement, have raised con-
siderable controversy (Mastroianni and Kahn
2002). Although these trials are usually
intended to benefit disadvantaged children,
they raise uncomfortable questions about why
an affluent society allows children to live in sub-
standard housing or hazardous environments.
Moreover, many people assume that experi-
mental trials of environmental toxicants would
require intentionally exposing children to envi-
ronmental hazards. But these trials can also be
conducted by randomly assigning children to
receive an intervention to reduce an existing
exposure (Lanphear et al. 1999; Morgan et al.
2004; Roberts et al. 1996). 
Guidelines for the ethical conduct of envi-
ronmental research involving children are
needed, especially for prevention trials involv-
ing disadvantaged children who are at
increased risk for environmentally induced
disease and disability. It is also important to
deﬁne minimal risk for the average “healthy”
child. It would be “unjust, a kind of societally
induced double jeopardy” to allow children
who live in violent neighborhoods or who face
greater-than-average environmental health
hazards to encounter greater risks from
research than the average healthy child
(Wendler 2005). Still, studies that primarily
involve disadvantaged children can be done
ethically when they examine hazards that pre-
dominantly affect disadvantaged children
(National Research Council and Institute of
Medicine 2005), but it is critical that any
research ﬁndings can ultimately be translated
to beneﬁt disadvantaged children. 
Not all environmental hazards should
be—or need to be—studied using random-
ized controlled trials. Several criteria should
be met before conducting a randomized con-
trolled trial of an environmental hazard that
involves children (Appendix 1). As reviewed
by Glantz (2002), some have argued that it is
unethical to enroll normal or healthy children
in research that does not offer the prospect of
beneﬁt. It is, of course, not possible to guar-
antee that subjects will beneﬁt by participat-
ing in a research study. But studies can be
designed to enhance the likelihood that sub-
jects will beneﬁt. In a controlled trial of lead
abatement, for example, the control group
could receive an injury reduction intervention
(Rhoads et al. 1999). Alternatively, the inter-
vention could be delayed in the control group
(Krieger et al. 2005). 
Definition of risk and benefit. Children
should not be enrolled in research with
greater than minimal risk unless it offers them
a prospect of benefit [Department of
Health and Human Services (DHHS) 1991].
Institutional review boards (IRBs) categorize
studies by their potential risk and benefit.
There are three primary categories of research
involving children: a) research that involves
no greater than minimal risk; b) research that
involves greater than minimal risk, but the
risk is justified by the anticipated benefit to
the participants; and c) research that involves
greater than minimal risk and no prospect of
direct beneﬁt to research participants, but the
risk represents only a minor increase over
minimal risk, the research involves experience
reasonably commensurate with those inherent
in the child’s situation, or the research is
likely to yield generalizable, vitally important
knowledge about a child’s disorder or condi-
tion. (DHHS 1991). 
IRBs need a clearer interpretation of the
standard of minimal risk (Wendler 2005).
Minimal risk, which is based on the level of
risk rather than the kinds of activities children
ordinarily encounter, is difficult to apply.
Federal regulations define minimal risk as
“the risk of harm or discomfort ordinarily
encountered in daily life or the performance
of routine physical or psychological examina-
tions or tests” (DHHS 1991). But the risks
ordinarily encountered in daily life are typi-
cally greater than what IRBs allow for
research subjects (Wendler 2005). Given this
vague guidance, it is not surprising that IRBs
are inconsistent in their categorization of tests
as posing a “minimal risk.” In a national sur-
vey of IRB chairpersons, a single blood draw
was categorized as minimal risk by 81%
respondents, whereas allergy skin testing was
categorized as minimal risk by only 23% of
respondents (Shah et al. 2004). 
Privacy. Information that is collected
about children for research purposes may
require more than conventional privacy pro-
tections, especially for longitudinal studies.
Outcomes that may not become manifest
until years later require long-term data storage
and analysis of data, years after a pregnancy is
completed or a child is grown. Data cannot be
completely deidentiﬁed because they will need
to be linked with subsequently collected data.
Given the lapses between data collection peri-
ods and children’s developing ability to under-
stand their rights, the privacy rights of
children who are participating in longitudinal
studies are best protected by viewing parental
permission and child assent as an ongoing
process that is repeated at appropriate intervals
(Fisher et al. 1996). 
Reporting results of environmental contam-
ination and body burden. There is considerable
controversy and uncertainty about whether to
report individual results to study subjects. The
National Bioethics Advisory Commission
(1999) recommends disclosing individual
results only when the ﬁndings are scientiﬁcally
valid and conﬁrmed; the ﬁndings have signiﬁ-
cant implications for the subject’s heath con-
cerns; and a course of action to ameliorate or
treat these concerns is readily available. Some
ethicists, however, argue that respect for
research participants requires investigators to
provide individual results to study participants,
except in unusual circumstances (Shalowitz and
Miller 2005). 
Most environmental health researchers
and community advocates would agree that
commonly used clinical tests or biomarkers
that conform to the National Bioethics
Advisory Commission’s criteria, such as blood
lead concentration and skin allergy testing,
should be reported promptly to families.
There is, however, considerable controversy
about reporting individual test results for bio-
markers that are not typically used in the clini-
cal setting or that have uncertain implications
Lanphear et al.
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demics tend to err on the side of withholding
information to minimize unnecessary anxiety,
whereas community advocates often argue
that families should receive tests that may be
indicative of harm. Should we report the
results of a pesticide or other environmental
chemicals found in a child’s blood to their
parent when there is little known about its
toxicity? Often the family can take action to
reduce their child’s exposure even before we
fully characterize the toxicity profile of an
environmental chemical. At a minimum, we
should adhere to what was promised in the
informed consent or consider making individ-
ual test results available when requested. 
Ethical Guidelines for
Environmental Research
Involving Children
Despite an extensive literature on the ethics of
conducting research on children and vulnera-
ble populations, there are no guidelines that
are speciﬁc for the ethical conduct of research
on environmental hazards involving children.
There are few aspects of consent, assent, and
genetic testing that distinguish environmental
health research from other research, but pro-
tecting children from environmental hazards
does raise some unique ethical issues. 
• As a society, we recognize that some of the
chemicals we intentionally put into the bod-
ies of humans (i.e., drugs) should be tested
for safety and efficacy prior to marketing.
Ultimately, there is no difference between
exposure to environmental teratogens and
pharmaceutical teratogens. For new chemi-
cals, we should demand regulations, such as
the REACH (Registration, Evaluation and
Authorisation of Chemicals) Program
proposed by the European Union, to ensure
that comprehensive toxicity testing is
conducted before a chemical is marketed
and widely disseminated (Claudio et al.
1999, 2000; European Commission 2004;
Goldman 2002; Lanphear et al. 2005b).
There is, however, no justification for
intentional dosing of healthy children with
chemicals for the purpose of evaluating
toxicity. 
• For persistent environmental hazards that are
widely disseminated in the environment, we
need guidelines to clarify when randomized
controlled trials are necessary to evaluate the
safety and efficacy of preventive efforts.
These guidelines should include recommen-
dations about the role of data safety monitor-
ing boards to identify adverse events and
terminate a study. 
• Guidelines are needed for reporting individ-
ual results of environmental contamination
and biomarkers of exposure to families who
are participating in a research study for both
conﬁrmed and suspected toxicants. 
• For environmental health research involving
children, IRBs need to ensure that commu-
nity representatives or a community advisory
board was involved in the design and imple-
mentation of the study (Mastroianni and
Kahn 2002). IRBs should have members
who have expertise in child health and com-
munity-based research (National Research
Council and Institute of Medicine 2005). 
• IRBs need clearer guidance for applying the
minimal risk standard, especially for environ-
mental hazards that primarily affect children
from vulnerable communities. 
Conclusion
Society has an obligation to protect children
from environmental toxicants and hazards. We
are increasingly aware of the profound impact
that environmental influences have on chil-
dren’s health. There are tragic accounts of out-
breaks of overt poisonings from industrial
chemicals and increasing recognition that low-
level exposure to environmental chemicals and
pollutants are linked with disease and disability
(Rogan 1995; Wigle and Lanphear 2005).
Research to examine environmental inﬂuences
on children is also expanding. As a result, there
is increasing public scrutiny and suspicion
about children’s exposures to environmental
hazards, especially for disadvantaged commu-
nities. These trends underscore the inadequacy
of current regulations to protect children from
suspected and conﬁrmed environmental toxi-
cants or hazards and the need for guidelines on
the ethical conduct of environmental health
research involving children. 
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